Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20014960
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\20014960
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Autoimmunity
2010 ; 43
(1
): 1-6
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Pathogenic mechanisms in systemic lupus erythematosus
#MMPMID20014960
Perl A
Autoimmunity
2010[Feb]; 43
(1
): 1-6
PMID20014960
show ga
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease
characterized by the dysfunction of T cells, B cells, and dendritic cells and by
the production of antinuclear autoantibodies. This editorial provides a synopsis
of newly discovered genetic factors and signaling pathways in lupus pathogenesis
that are documented in 11 state-of-the-art reviews and original articles.
Mitochondrial hyperpolarization underlies mitochondrial dysfunction, depletion of
ATP, oxidative stress, abnormal activation, and death signal processing in lupus
T cells. The mammalian target of rapamycin, which is a sensor of the
mitochondrial transmembrane potential, has been successfully targeted for
treatment of SLE with rapamycin or sirolimus in both patients and animal models.
Inhibition of oxidative stress, nitric oxide production, expression of endogenous
retroviral and repetitive elements such as HRES-1, the long interspersed nuclear
elements 1, Trex1, interferon alpha (IFN-alpha), toll-like receptors 7 and 9
(TLR-7/9), high-mobility group B1 protein, extracellular signal-regulated kinase,
DNA methyl transferase 1, histone deacetylase, spleen tyrosine kinase, proteasome
function, lysosome function, endosome recycling, actin cytoskeleton formation,
the nuclear factor kappa B pathway, and activation of cytotoxic T cells showed
efficacy in animal models of lupus. Although B cell depletion and blockade of
anti-DNA antibodies and T-B cell interaction have shown success in animal models,
human studies are currently ongoing to establish the value of several target
molecules for treatment of patients with lupus. Ongoing oxidative stress and
inflammation lead to accelerated atherosclerosis that emerged as a significant
cause of mortality in SLE.